Harnessing bacterial toxins to treat pain

Nat Neurosci. 2022 Feb;25(2):132-134. doi: 10.1038/s41593-021-00981-8.

Authors

Jimena Perez-Sanchez¹, David L Bennett²

Affiliations

¹ Neural Injury Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
² Neural Injury Group, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK. david.bennett@ndcn.ox.ac.uk.

PMID: 34931071
DOI: 10.1038/s41593-021-00981-8

No abstract available

Publication types

Comment

MeSH terms

Anthrax*
Bacterial Toxins* / therapeutic use
Humans
Pain / drug therapy
Receptors, Peptide
Sensory Receptor Cells
Signal Transduction

Substances

ANTXR2 protein, human
Bacterial Toxins
Receptors, Peptide

Grants and funding